SCHEMBL6844002

SCHEMBL6844002

Oc1ccc2ccc3ccc(O)nc3c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.43
CCR5 P51681 2/20 0.43
RAB9A P51151 1/20 0.43
METAP2 P50579 2/20 0.36
PLAU P00749 1/20 0.36
NCF1 P14598 1/20 0.36
KDM4E B2RXH2 3/20 0.35
CYP3A4 P08684 2/20 0.35
HIF1A Q16665 2/20 0.35
MMP2 P08253 2/20 0.35
TSHR P16473 2/20 0.35
GMNN O75496 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
HSP90AA1 P07900 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
MMP9 P14780 1/20 0.35
ALOX15 P16050 1/20 0.35
NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24508237 0.84 CCR1 (0.34) CCR1CCR5RAB9A
SCHEMBL4459734 0.81 PTPN22 (0.39) METAP2PLAUNCF1KDM4ECYP3A4
SCHEMBL169928 0.81 LMNA (0.70) CCR1CCR5METAP2KDM4ECYP3A4
SCHEMBL30519804 0.81 LMNA (0.70) CCR1CCR5METAP2KDM4ECYP3A4
SCHEMBL672744 0.79 METAP2 (0.63) RAB9AMETAP2PLAUNCF1KDM4E
SCHEMBL30082244 0.79 METAP2 (0.63) RAB9AMETAP2PLAUNCF1KDM4E
SCHEMBL8840923 0.78 MYC (0.37) RAB9AKDM4ECYP3A4HIF1ATSHR
SCHEMBL8467827 0.77 METAP2 (0.61) RAB9AMETAP2PLAUNCF1KDM4E
SCHEMBL1496246 0.77 METAP2 (0.61) RAB9AMETAP2PLAUNCF1KDM4E
SCHEMBL243820 0.77 HSD17B10 (0.48) RAB9AKDM4EHIF1ATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104380516-B Composition for gel polymer electrolyte and lithium secondary battery comprising the same 株式会社LG化学 2017-04-26 CN claimed
WO-2023008058-A1 FLOW BATTERY SYSTEM EMPLOYING REDOX CONTROL OF CO2 国立研究開発法人産業技術総合研究所 2023-02-02 WO disclosed
US-9856282-B2 Dehydrogenation catalyst, and carbonyl compound and hydrogen production method using said catalyst KANTO KAGAKU KABUSHIKI KAISHA (JP) 2018-01-02 US disclosed
US-9856282-B2 Dehydrogenation catalyst, and carbonyl compound and hydrogen production method using said catalyst KANTO KAGAKU KABUSHIKI KAISHA (JP) 2018-01-02 US disclosed
CN-104285330-B Lithium secondary battery 株式会社LG化学 2017-08-22 CN disclosed
CN-104380516-B Composition for gel polymer electrolyte and lithium secondary battery comprising the same 株式会社LG化学 2017-04-26 CN disclosed
CN-104203892-B Dehydrogenation catalyst, and carbonyl compound and hydrogen production method using said catalyst 关东化学株式会社 2017-03-22 CN disclosed
US-20160297844-A1 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2016-10-13 US disclosed
US-20160297844-A1 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2016-10-13 US disclosed
US-20160297844-A1 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2016-10-13 US disclosed
US-9403159-B2 Dehydrogenation catalyst, and carbonyl compound and hydrogen production method using said catalyst KANTO KAGAKU KABUSHIKI KAISHA (JP) 2016-08-02 US disclosed
US-20160008801-A9 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2016-01-14 US disclosed
US-20160008801-A9 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2016-01-14 US disclosed
US-20160008801-A9 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2016-01-14 US disclosed
US-20150086473-A1 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2015-03-26 US disclosed
US-20150086473-A1 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2015-03-26 US disclosed
US-20150086473-A1 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST KANTO KAGAKU KABUSHIKI KAISHA (JP) 2015-03-26 US disclosed
US-6770760-B2 METAL COMPLEXEX FOR USE AS DIAGNOSTIC TOOL IN GNETIC ANALYSIS ACADEMIA SINICA (TW) 2004-08-03 US disclosed
US-20020095029-A1 Nucleic acid bulge-detecting agent ACADEMIA SINICA, A TAIWAN CORPORATION 2002-07-18 US disclosed
US-6348588-B1 Method of cleaving a nucleic acid bulge ACADEMIA SINICA (TW) 2002-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297844-A1 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST ADH1C, ADH1A, ADH5 CCR1 940/4885CCR5 973/4885RAB9A 2648/4885
US-20160008801-A9 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST ADH1C, ADH1A, ADH5 CCR1 940/4885CCR5 973/4885RAB9A 2648/4885
US-20150086473-A1 DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST ADH1C, ADH1A, ADH5 CCR1 940/4885CCR5 973/4885RAB9A 2648/4885
US-20020095029-A1 Nucleic acid bulge-detecting agent NSUN3, POLRMT, MUS81 CCR1 3416/4885CCR5 3225/4885RAB9A 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.